Kingsview Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.8M | Sell |
36,365
-1,447
| -4% | -$516K | 0.17% | 110 |
|
|
2025
Q4 | $12.4M | Sell |
37,812
-2,920
| -7% | -$926K | 0.18% | 108 |
|
|
2025
Q3 | $11.5M | Buy |
40,732
+481
| +1% | +$139K | 0.18% | 107 |
|
|
2025
Q2 | $11.2M | Sell |
40,251
-1,334
| -3% | -$378K | 0.19% | 90 |
|
|
2025
Q1 | $13M | Sell |
41,585
-7,001
| -14% | -$2.07M | 0.24% | 75 |
|
|
2024
Q4 | $12.7M | Buy |
48,586
+3,314
| +7% | +$983K | 0.25% | 74 |
|
|
2024
Q3 | $14.6M | Buy |
45,272
+12,430
| +38% | +$4.07M | 0.31% | 57 |
|
|
2024
Q2 | $10.3M | Sell |
32,842
-30,610
| -48% | -$8.99M | 0.24% | 80 |
|
|
2024
Q1 | $18M | Buy |
63,452
+5,819
| +10% | +$1.7M | 0.45% | 42 |
|
|
2023
Q4 | $16.6M | Buy |
57,633
+8,282
| +17% | +$2.26M | 0.5% | 42 |
|
|
2023
Q3 | $13.3M | Buy |
49,351
+4,376
| +10% | +$1.09M | 0.48% | 43 |
|
|
2023
Q2 | $9.99M | Buy |
44,975
+281
| +0.6% | +$65.2K | 0.39% | 55 |
|
|
2023
Q1 | $10.8M | Sell |
44,694
-1,712
| -4% | -$420K | 0.45% | 51 |
|
|
2022
Q4 | $12.2M | Buy |
46,406
+1,046
| +2% | +$280K | 0.53% | 35 |
|
|
2022
Q3 | $10.2M | Buy |
45,360
+1,588
| +4% | +$385K | 0.49% | 45 |
|
|
2022
Q2 | $10.7M | Buy |
43,772
+1,121
| +3% | +$275K | 0.51% | 39 |
|
|
2022
Q1 | $10.3M | Buy |
42,651
+355
| +0.8% | +$81.6K | 0.45% | 45 |
|
|
2021
Q4 | $9.52M | Buy |
42,296
+1,739
| +4% | +$367K | 0.4% | 53 |
|
|
2021
Q3 | $8.63M | Buy |
40,557
+1,754
| +5% | +$404K | 0.41% | 46 |
|
|
2021
Q2 | $9.57M | Sell |
38,803
-5,443
| -12% | -$1.34M | 0.47% | 36 |
|
|
2021
Q1 | $11M | Buy |
44,246
+3,607
| +9% | +$861K | 0.63% | 28 |
|
|
2020
Q4 | $9.34M | Sell |
40,639
-1,452
| -3% | -$335K | 0.68% | 27 |
|
|
2020
Q3 | $10.7M | Buy |
42,091
+2,339
| +6% | +$579K | 0.96% | 13 |
|
|
2020
Q2 | $9.38M | Sell |
39,752
-1,975
| -5% | -$451K | 0.94% | 13 |
|
|
2020
Q1 | $8.46M | Buy |
41,727
+24,572
| +143% | +$5.37M | 1.14% | 13 |
|
|
2019
Q4 | $4.14M | Buy |
17,155
+3,905
| +29% | +$861K | 0.52% | 52 |
|
|
2019
Q3 | $2.56M | Buy |
13,250
+1,133
| +9% | +$217K | 0.4% | 68 |
|
|
2019
Q2 | $2.23M | Buy |
12,117
+486
| +4% | +$87K | 0.37% | 73 |
|
|
2019
Q1 | $2.21M | Buy |
11,631
+2,276
| +24% | +$435K | 0.34% | 81 |
|
|
2018
Q4 | $1.82M | Buy |
9,355
+276
| +3% | +$53.8K | 0.4% | 75 |
|
|
2018
Q3 | $1.88M | Buy |
9,079
+185
| +2% | +$36.5K | 0.38% | 77 |
|
|
2018
Q2 | $1.64M | Buy |
8,894
+4,401
| +98% | +$778K | 0.39% | 79 |
|
|
2018
Q1 | $766K | Sell |
4,493
-5,377
| -54% | -$987K | 0.19% | 145 |
|
|
2017
Q4 | $1.15M | Buy |
9,870
+7,800
| +377% | +$1.38M | 0.41% | 64 |
|
|
2017
Q3 | $386K | Sell |
2,070
-817
| -28% | -$145K | 0.17% | 170 |
|
|
2017
Q2 | $497K | Buy |
2,887
+1,100
| +62% | +$179K | 0.26% | 124 |
|
|
2017
Q1 | $293K | Buy |
+1,787
| New | +$297K | 0.17% | 177 |
|
Other funds holding AMGN
VCM
VPM
Kingsview Wealth Management's AMGN Position: Q1 2026 in Review
Kingsview Wealth Management reduced its Amgen (AMGN) stake by 3.8% in Q1 2026, selling an estimated $516K and leaving 36,365 shares worth $12.8M. The position accounts for 0.17% of the portfolio, ranked #110.
Kingsview Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 37 quarters since. The position peaked at $18M in Q1 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Kingsview Wealth Management held 36,365 shares of Amgen worth $12.8M as of Q1 2026.
- Kingsview Wealth Management sold 1,447 Amgen shares in Q1 2026, an estimated $516K.
- Amgen made up 0.17% of Kingsview Wealth Management's portfolio in Q1 2026, its #110 holding.
- Kingsview Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 37 quarters since.
- Kingsview Wealth Management's Amgen position peaked at $18M in Q1 2024.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.